Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2022-04-19 Purchase | 2022-04-21 6:04 pm | Inozyme Pharma Inc. | INZY | Longitude Capital Partners III LLC Longitude Venture Partners III L.P. Tammenoms Bakker Juliet ENRIGHT PATRICK G 10% Owner | 1,355,000 | $3.69 | $4,999,950 | 4,174,379 (Indirect) | View |
| 2022-02-02 Purchase | 2022-02-02 9:25 pm | Sierra Oncology Inc. | SRRA | Longitude Capital Partners III LLC Longitude Venture Partners III L.P. Tammenoms Bakker Juliet ENRIGHT PATRICK G Longitude Prime Partners LLC Longitude Prime Fund L.P. 10% Owner | 175,000 | $27 | $4,725,000 | 2,139,771 (Indirect) | View |
| 2021-05-11 Purchase | 2021-05-11 8:29 pm | Talaris Therapeutics Inc. | TALS | Longitude Capital Partners III LLC Longitude Venture Partners III L.P. ENRIGHT PATRICK G Tammenoms Bakker Juliet 10% Owner | 235,000 | $17 | $3,995,000 | 3,220,775 (Indirect) | View |
| 2020-08-28 Sale | 2020-09-01 7:33 pm | Molecular Templates Inc. | MTEM | Longitude Capital Partners III LLC Longitude Venture Partners III L.P. ENRIGHT PATRICK G Tammenoms Bakker Juliet 10% Owner | 3,496 | $10.75 | $37,568 | 3,202,530 (Indirect) | View |
| 2020-07-28 Purchase | 2020-07-28 6:20 pm | Inozyme Pharma Inc. | INZY | Longitude Capital Partners III LLC Longitude Venture Partners III L.P. Tammenoms Bakker Juliet ENRIGHT PATRICK G 10% Owner | 625,000 | $16 | $10,000,000 | 2,819,379 (Indirect) | View |
| 2020-07-10 Purchase | 2020-07-14 8:11 pm | 89bio Inc. | ETNB | Longitude Capital Partners III LLC Longitude Venture Partners III L.P. Tammenoms Bakker Juliet ENRIGHT PATRICK G 10% Owner | 109,090 | $27.5 | $2,999,975 | 2,600,877 (Indirect) | View |
| 2019-11-25 Purchase(A) | 2019-12-05 4:16 pm | Molecular Templates Inc. | MTEM | Longitude Capital Partners III LLC Longitude Venture Partners III L.P. ENRIGHT PATRICK G Tammenoms Bakker Juliet 10% Owner | 937,500 | $8 | $7,500,000 | 4,199,035 (Indirect) | View |
| 2019-11-25 Purchase | 2019-11-27 4:47 pm | Molecular Templates Inc. | MTEM | Longitude Capital Partners III LLC Longitude Venture Partners III L.P. ENRIGHT PATRICK G Tammenoms Bakker Juliet 10% Owner | 937,000 | $8 | $7,496,000 | 4,198,535 (Indirect) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2022-04-27 Other | 2022-04-29 7:07 pm | N/A N/A | Sierra Oncology Inc. | SRRA | Longitude Capital Partners III LLC Longitude Venture Partners III L.P. Tammenoms Bakker Juliet ENRIGHT PATRICK G Longitude Prime Partners LLC Longitude Prime Fund L.P. 10% Owner | 2,155,801 | $0 | 2,163,816 (Indirect) | View |
| 2022-01-25 Exercise | 2022-01-27 9:23 pm | 2020-01-22 2022-04-10 | Sierra Oncology Inc. | SRRA | Longitude Capital Partners III LLC Longitude Venture Partners III L.P. Tammenoms Bakker Juliet ENRIGHT PATRICK G 10% Owner | 1,964,576 | $13.2 | 1,964,771 (Indirect) | View |
| 2021-05-11 Conversion | 2021-05-11 8:29 pm | N/A N/A | Talaris Therapeutics Inc. | TALS | Longitude Capital Partners III LLC Longitude Venture Partners III L.P. ENRIGHT PATRICK G Tammenoms Bakker Juliet 10% Owner | 5,971,550 | $0 | 3,220,775 (Indirect) | View |
Ownership | 2021-05-06 9:25 pm | N/A N/A | Talaris Therapeutics Inc. | TALS | Longitude Capital Partners III LLC Longitude Venture Partners III L.P. ENRIGHT PATRICK G Tammenoms Bakker Juliet 10% Owner | 0 | $0 | 2,985,775 (Indirect) | View |
| 2020-11-16 Other | 2020-11-18 7:11 pm | N/A N/A | 89bio Inc. | ETNB | Longitude Capital Partners III LLC Longitude Venture Partners III L.P. Tammenoms Bakker Juliet ENRIGHT PATRICK G 10% Owner | 855,944 | $0 | 856,835 (Indirect) | View |
| 2020-07-28 Conversion | 2020-07-28 6:20 pm | N/A N/A | Inozyme Pharma Inc. | INZY | Longitude Capital Partners III LLC Longitude Venture Partners III L.P. Tammenoms Bakker Juliet ENRIGHT PATRICK G 10% Owner | 18,592,979 | $0 | 2,819,379 (Indirect) | View |
Ownership | 2020-07-23 9:26 pm | N/A N/A | Inozyme Pharma Inc. | INZY | Longitude Capital Partners III LLC Longitude Venture Partners III L.P. Tammenoms Bakker Juliet ENRIGHT PATRICK G 10% Owner | 0 | $0 | 2,194,379 (Indirect) | View |
| 2020-05-26 Other | 2020-05-28 9:07 pm | N/A N/A | Molecular Templates Inc. | MTEM | Longitude Capital Partners III LLC Longitude Venture Partners III L.P. ENRIGHT PATRICK G Tammenoms Bakker Juliet 10% Owner | 1,006,991 | $0 | 1,008,040 (Indirect) | View |
| 2020-01-29 Conversion | 2020-01-31 5:45 pm | N/A N/A | Sierra Oncology Inc. | SRRA | Longitude Capital Partners III LLC Longitude Venture Partners III L.P. Tammenoms Bakker Juliet ENRIGHT PATRICK G 10% Owner | 1,496,820 | $0 | 1,477,320 (Indirect) | View |
Ownership | 2019-11-26 8:56 pm | N/A N/A | Sierra Oncology Inc. | SRRA | Longitude Capital Partners III LLC Longitude Venture Partners III L.P. Tammenoms Bakker Juliet ENRIGHT PATRICK G 10% Owner | 0 | $0 | 137,668,050 (Indirect) | View |